Clinical Trial Update: Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Nuwiq (recombinant factor VIII) for perioperative management in patients with Hemophilia A on emicizumab prophylaxis; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Hemlibra (emicizumab)
• Nuwiq (recombinant factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Severe Hemophilia A | Phase 4 | Status: RECRUITING